FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Saroja Pharma Industries IPO and Unihealth Consultancy IPO.
Saroja Pharma Industries IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Unihealth Consultancy IPO is a SME Book Built Issue proposed to list at NSE SME.
Saroja Pharma Industries IPO | Unihealth Consultancy IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Swastika Investmart Ltd | Unistone Capital Pvt Ltd |
Registrar | Kfin Technologies Limited | Bigshare Services Pvt Ltd |
Market Maker | Swastika Investmart Limited | Rikhav Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Saroja Pharma Industries IPO is up to ₹9.11 Cr whereas the issue size of the Unihealth Consultancy IPO is up to ₹56.55 Cr. The final issue price of Saroja Pharma Industries IPO is ₹84.00 per share and of Unihealth Consultancy IPO is ₹132.00 per share.
Saroja Pharma Industries IPO | Unihealth Consultancy IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹126.00 per share | |
Issue Price (Upper) | ₹132.00 per share | |
Issue Price (Final) | ₹84.00 per share | ₹132.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 1000 shares |
Fresh Issue Size | 10,84,800 shares | 42,84,000 shares |
Fresh Issue Size (Amount) | up to ₹9.11 Cr | up to ₹56.55 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 10,84,800 shares | 42,84,000 shares |
Issue Size Total (Amount) | up to ₹9.11 Cr | up to ₹56.55 Cr |
Saroja Pharma Industries IPO opens on Aug 31, 2023, while Unihealth Consultancy IPO opens on Sep 08, 2023. The closing date of Saroja Pharma Industries IPO and Unihealth Consultancy IPO is Sep 05, 2023, and Sep 12, 2023, respectively.
Saroja Pharma Industries IPO | Unihealth Consultancy IPO | |
---|---|---|
Anchor Bid Date | Sep 07, 2023 | |
Issue Open | Aug 31, 2023 | Sep 08, 2023 |
Issue Close | Sep 05, 2023 | Sep 12, 2023 |
Basis Of Allotment (Tentative) | Sep 08, 2023 | Sep 15, 2023 |
Initiation of Refunds (Tentative) | Sep 11, 2023 | Sep 18, 2023 |
Credit of Share (Tentative) | Sep 12, 2023 | Sep 20, 2023 |
Listing date (Tentative) | Sep 13, 2023 | Sep 21, 2023 |
Anchor Lockin End date 1 | Oct 08, 2023 | Oct 15, 2023 |
Anchor Lockin End date 2 | Dec 07, 2023 | Dec 14, 2023 |
Saroja Pharma Industries IPO P/E ratio is 23.27, as compared to Unihealth Consultancy IPO P/E ratio of 19.02.
Saroja Pharma Industries IPO | Unihealth Consultancy IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Lakhs |
Amount in ₹ Lakhs |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00% | 95.32% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.02% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 23.27 | 19.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹33.77 Cr. | ₹203.28 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 0.15%% | 36.19%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 0.25%% | 20.99%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2 | 1.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹3.61 | ₹6.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 20.85%% | 27.91%% |
In the Saroja Pharma Industries IPO retail investors (RII) are offered 5,15,200 shares while in Unihealth Consultancy IPO retail investors are offered 5,15,200 shares. Qualified institutional buyers (QIB) are offered 0 shares in Saroja Pharma Industries IPO and 20,34,000 shares in Unihealth Consultancy IPO.
Saroja Pharma Industries IPO | Unihealth Consultancy IPO | |
---|---|---|
Anchor Investor Reserveration | 12,18,000 shares | |
Market Maker Reserveration | 54,400 shares | 2,16,000 shares |
QIB | 0 shares | 20,34,000 shares |
NII | 5,15,200 shares | 6,10,200 shares |
RII | 5,15,200 shares | 14,23,800 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 10,30,400 shares | 38,52,000 shares |
Saroja Pharma Industries IPO subscribed 8.88x in total, whereas Unihealth Consultancy IPO subscribed 18.22x.
Saroja Pharma Industries IPO | Unihealth Consultancy IPO | |
---|---|---|
QIB (times) | 5.97x | |
NII (times) | 2.90x | 37.65x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 14.83x | 24.61x |
Employee (times) | ||
Other (times) | ||
Total (times) | 8.88x | 18.22x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|